Elsevier's Maturitas Publishes Position Statement on the Topic of Late Parenthood
AMSTERDAM, September 3, 2013 /3BL Media/ – Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of a position statement by the European Menopause and Andropause Society (EMAS) in the journal Maturitas on the topic of late parenthood.
Couples have been delaying parenthood with an average increase of one year per decade since the 1970s. However, advanced parental age is associated with infertility and pregnancy complications and may have an impact on long-term offspring health. The EMAS’ position statement recommends that all adults of reproductive age should receive counseling about the risks involved surrounding advanced parental age, so they can make informed decisions about the timing of childbearing. At the same time, all parents-to-be of advanced age should receive advice regarding their pregnancy, neonatal and long-term offspring health-related issues. These tasks require an interdisciplinary approach that should lead to patient-centered, informed decision-making strategies.
These and other recommendations presented in EMAS’ position statement are published in the article: “EMAS position statement: Late parenthood” by Gesthimani Mintziori, Irene Lambrinoudaki, Efstratios M. Kolibianakis, Iuliana Ceausu, Herman Depypere, C. Tamer Erel, Faustino R. Pérez-López, Karin Schenck-Gustafsson, Yvonne van der Schouw, Tommaso Simoncini, Florence Tremollieres, Basil C. Tarlatzis, Margaret Rees and Dimitrios G. Goulis (10.1016/j.maturitas.2013.07.008).The article appears in Maturitas Volume 76, Issue 2 (October 2013), published by Elsevier.
Notes for editors
Full text of the article is available to credentialed journalists upon request, contact newsroom@elsevier.com. For further details about the clinical guide or to contact the authors or EMAS, contact: g.peoples@elsevier.com, +31 20 485 3323
About the European Menopause and Andropause Society (EMAS)
EMAS promotes the study of midlife health through its journal, congresses, schools and website and encourages the exchange of research and professional experience between members.
Using a range of activities and through its affiliates, EMAS aims to guarantee and provide the same standard of education and information throughout Europe on midlife health in both genders. Recognizing the issues arising from increased longevity the society also provides articles, patient information, web resources, and referrals for healthcare providers in the field and keeps its members up-to-date. For more information go to: www.emas-online.org
About Maturitas
Maturitas is an international multidisciplinary peer reviewed scientific journal of midlife health and beyond, publishing original research, reviews, consensus statements and guidelines. The scope encompasses all aspects of postreproductive health in both genders ranging from basic science to health and social care. http://www.maturitas.org/
About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV.
Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.
Media contact
Greyling Peoples
Elsevier
+31 20 485 3323
g.peoples@elsevier.com
